Oda Hisanobu

オダヒサノブ | Oda Hisanobu

Affiliation and department：
Other affiliations (1)：

消化管•腫瘍内科

Homepage URL (1)： http://kaken.nii.ac.jp/d/r/30295133.ja.html

Research field (2)： Medical biochemistry , Gastroenterology

Research keywords (13)： DNA repair , Epigenetics , Colorectal cancer , Gastric cancer , 大腸癌 , 胃癌 , 腫瘍生物学 , histone methytransferase , PR-Set7/set8 , DNA修復 , ヒストンメチル化 , 発癌 , エピジェネティクス

Research theme for competitive and other funds (3)：

2014 - 2016 Function of histone methyltransferase PR-set7 and its relationship to carcinogenesis
2011 - 2013 Analysis of chromatin function mediated by histone H4 lysine 20 methylation
1998 - 1999 ヒトMTH1蛋白質群の生成と消化器癌の発癌感受性に関する研究

Papers (22)：

Hirofumi Ohmura, Kyoko Yamaguchi, Fumiyasu Hanamura, Mamoru Ito, Akitaka Makiyama, Keita Uchino, Hozumi Shimokawa, Shingo Tamura, Taito Esaki, Kenji Mitsugi, et al. OX40 and LAG3 are associated with better prognosis in advanced gastric cancer patients treated with anti-programmed death-1 antibody. British journal of cancer. 2020. 122. 10. 1507-1517
Hirofumi Ohmura, Kyoko Yamaguchi, Fumiyasu Hanamura, Tanoue Kenrou, Shiho Kawagoe, Kohei Arimizu, Yuzo Matsushita, Tatsuhiro Kajitani, Shingo Tamura, Hozumi Shimokawa, et al. Activation of memory/effector T cells and association between prognosis and OX40-positive T cells in advanced head and neck cancer patients treated with anti-programmed death-1 antibody. Journal of Clinical Oncology. 2020. 38. 5_suppl. 35-35
Hirofumi Ohmura, Kyoko Yamaguchi, Fumiyasu Hanamura, Mamoru Ito, Akitaka Makiyama, Keita Uchino, Hozumi Shimokawa, Taito Esaki, Kenji Mitsugi, Yoshihiro Shibata, et al. Activation of central/effector memory T cells in advanced gastric cancer patients treated with antiprogrammed death-1 antibody. Journal of Clinical Oncology. 2019. 37. 4_suppl. 54-54
Akitaka Makiyama, Kohei Arimizu, Gen Hirano, Chinatsu Makiyama, Yuzo Matsushita, Tsuyoshi Shirakawa, Hirofumi Ohmura, Masato Komoda, Keita Uchino, Kyoko Inadomi, et al. Irinotecan monotherapy as third-line or later treatment in advanced gastric cancer. Gastric Cancer. 2018. 21. 3. 464-472
Mamoru Ito, Hitoshi Kusaba, Satomi Mukaide, Junji Kishimoto, Hozumi Shimokawa, Shingo Tamura, Akitaka Makiyama, Gen Hirano, Hisanobu Oda, Tsuyoshi Shirakawa, et al. Early tumor shrinkage indicates a favorable response to bevacizumab-based first-line chemotherapy for metastatic colorectal cancer. ANTI-CANCER DRUGS. 2017. 28. 10. 1166-1173

ｍore...

MISC (27)：

Yudai Shinohara, Miyuki Kuwayama, Tatsuhiro Kajitani, Hisanobu Oda, Taito Esaki. Our experience of chemotherapy with ramucirumab in combination with paclitaxel. ANNALS OF ONCOLOGY. 2016. 27
Miyuki Kuwayama, Hisanobu Oda, Fumiyoshi Fushimi, Yudai Shinohara, Tatsuhiro Kajitani, Kenichi Taguchi, Taito Esaki. ARID1A expression in advanced gastric cancer: Correlation with clinical outcome and response to firstline chemotherapy. ANNALS OF ONCOLOGY. 2016. 27
Mamoru Tanaka, Hitoshi Kusaba, Satomi Mukaide, Junji Kishimoto, Hozumi Kumagai, Akitaka Makiyama, Tsuyoshi Shirakawa, Hisanobu Oda, Masato Komoda, Kenji Mitsugi, et al. Exploratory analysis of a prognosis predictive formula for metastatic colorectal cancer treated with chemotherapy. JOURNAL OF CLINICAL ONCOLOGY. 2015. 33. 3
Mamoru Tanaka, Hozumi Kumagai, Junji Kishimoto, Satomi Mukaide, Hisanobu Oda, Kenji Mitsugi, Akitaka Makiyama, Masato Komoda, Hitoshi Kusaba, Eishi Baba. EXPLORATORY ANALYSIS OF A PROGNOSIS PREDICTIVE MODEL FOR METASTATIC COLORECTAL CANCER TREATED WITH CHEMOTHERAPY. ANNALS OF ONCOLOGY. 2014. 25
Tatsuhiro Kajitani, Akitaka Makiyama, Shuji Arita, Hozumi Kumagai, Hisanobu Oda, Tsuyoshi Shirakawa, Taito Esaki. ANTI-EGFR ANTIBODY RECHALLENGE IN CHEMOREFRACTORY PATIENTS WITH METASTATIC COLORECTAL CANCER. ANNALS OF ONCOLOGY. 2014. 25

ｍore...

Education (2)：

1993 - 1997 九州大学大学院医学系研究科
1983 - 1989 Kyushu University School of Medicine

Professional career (1)：

医学博士 (九州大学)

Work history (2)：

2010 - 2014 National Hospital Organization
2006 - 2010 New York University School of Medicine Department of Biochemistry

Association Membership(s) (5)：

JAPAN SOCIETY OF CLINICAL ONCOLOGY , THE MOLECULAR BIOLOGY SOCIETY OF JAPAN , THE JAPANESE SOCIETY OF INTERNAL MEDICINE , THE JAPANESE CANCER ASSOCIATION , THE JAPANESE SOCIETY OF MEDICAL ONCOLOGY

※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page